Skip to content

Research Library · Study page

Is there good evidence for Irlen syndrome? A 2019 review of 45 studies

Five researchers in Brazil looked at 45 studies. They found a "lack of evidence" that Irlen syndrome exists as described, or that lenses treat it.

Study Facts

Miyasaka and others, 2019

Review of 45 studies

Question
Is there good evidence for Irlen syndrome?

What it found

A "lack of evidence" that Irlen syndrome exists as described, or that colored lenses treat it.

EvidenceLimited

A wide search, but no pooled result, and weak studies.

Kids
People in studies of Irlen syndrome
Ages
Children and adults
Size
45 studies, 3,963 people
Fair tests
15 of 45 studies had no proper comparison group
Measured
How it was found, and whether lenses helped reading
By
5 researchers, a medical school in Brazil
Paid by
Not stated
Conflicts
None, the authors say

Jordan Da Silva Miyasaka, Raphael V. Gonzaga Vieira, Elaine Shizue Novalo-Goto, Erik Montagna and Rubens Wajnsztejn (2019). “Irlen syndrome: systematic review and level of evidence analysis.” Arquivos de Neuro-Psiquiatria, 77(3), 194–207. Read the free full text · Publisher's version
Free to read on the publisher's site. This is the copy we read.

Last reviewed November 17, 2026 · Used in: Do colored overlays help with dyslexia?

Go deeper

The study in eight short parts. Tap a part to open it.

1

What is the study?

Five researchers at a medical school in Brazil wrote this review. It looked at 45 studies of Irlen syndrome, with 3,963 people in all. It asked what causes it, how it is found, and whether treatment works.

Irlen syndrome has other names too, the review notes. It is a name for trouble seeing print.

2

Why this matters to you

It is the only review we read that is about Irlen syndrome by name. If someone suggests an Irlen test, this review says what the studies show.

3

What was measured?

How each study found Irlen syndrome. What was tried. And whether reading got better.

The review also graded how strong each study's evidence was.

4

Who was measured?

No one, directly. The paper measured no people of its own. The 45 studies it read covered children and adults, aged 4 to 73.

5

How was it measured?

  • A wide search, then a summary of each study.
  • A grade for each study. Most were low on the review's scale.
  • No pooled number. The studies varied too much and had "critical biases", the authors write.
  • Weak designs. 15 of the 45 studies had no proper comparison group. Only two planned their size in advance.
6

The results

A "lack of evidence". The review found a "lack of evidence on the existence of IS and treatment effectiveness". In plain words: a lack of evidence that Irlen syndrome exists as described, or that colored lenses treat it.

Not ruled out. The evidence does "not allow us to completely refute" the syndrome's symptoms, the authors write. People do report these symptoms.

Split findings. 14 studies backed the lenses or the syndrome. 14 found the opposite. Five said the evidence was unclear. Four asked for more study. The other eight came to other views.

The tests. The review found ten tests for Irlen syndrome. Seven were privately owned and patented. The authors call the tests "at least questionable".

The test and the treatment overlap. Colored lenses were one of the tools used to find the syndrome, the review notes. The authors say this muddies the results.

Who wrote the studies. One author appears in 11 of the 45 studies, the review counts. Another appears in 10. That author owns several patents on finding and treating the syndrome, the review adds.

Placebo. The placebo effect is the reason most often given for the gains people report, the review says.

Not in the medical index. PubMed, the main list of medical research, has no index entry for it, under any of its names, the review notes.

What doctors' groups say, as the review reports it. The American Academy of Ophthalmology and the American Academy of Pediatrics do not recommend colored lenses for reading problems, the review reports. We have not read their statement.

The authors' conclusion. "The prescription of colored lenses specifically for this spectrum of symptoms should not be recommended", they write.

7

Why this matters to you, again

  • Weak evidence on both counts. There is a lack of evidence for the syndrome as described, and for the lenses.
  • The symptoms are not ruled out. The review does not say people imagine them.
  • Many stop. About half of the lens users in one group of children gave the lenses up after a year, the review reports.

This page is not medical advice.

The paper's own limits:

  • No pooled analysis was possible.
  • Not a full refutation. It cannot completely rule out the symptoms.
  • Left out. It did not include reviews, letters, theses, work that was not peer reviewed, or papers in languages the authors could not read.
  • Shared samples. Three of the 45 studies shared one group of patients, and others reused samples.

A caution of ours: this review describes some other papers in ways their own text does not support. We use it only for its own search, its own counts and its own conclusions.

8

Who did the study, and who paid

Who did it. Five researchers at ABC Medical School (Faculdade de Medicina do ABC) in Santo André, Brazil.

Who paid. Not stated.

Conflicts of interest. None, the authors say.